Compare CRIS & USIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRIS | USIO |
|---|---|---|
| Founded | 2000 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.6M | 58.8M |
| IPO Year | 2000 | 1999 |
| Metric | CRIS | USIO |
|---|---|---|
| Price | $1.10 | $2.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $17.00 | $4.00 |
| AVG Volume (30 Days) | 128.4K | ★ 346.6K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.57 | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | $9,898,000.00 | ★ $28,200,535.00 |
| Revenue This Year | $27.10 | $12.15 |
| Revenue Next Year | $67.74 | $8.57 |
| P/E Ratio | ★ N/A | $230.00 |
| Revenue Growth | ★ 31.50 | 12.69 |
| 52 Week Low | $0.18 | $1.03 |
| 52 Week High | $6.74 | $3.06 |
| Indicator | CRIS | USIO |
|---|---|---|
| Relative Strength Index (RSI) | 22.99 | 37.78 |
| Support Level | $0.80 | $2.11 |
| Resistance Level | $1.21 | $2.61 |
| Average True Range (ATR) | 0.11 | 0.18 |
| MACD | 0.04 | -0.08 |
| Stochastic Oscillator | 9.44 | 1.30 |
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Usio Inc is a cloud-based Fintech payment processor. The company serves multiple industry verticals with technology that facilitates payment acceptance and funds disbursement in a single, full-stack ecosystem. It provides payment acceptance through multiple payment methods, including payment facilitation, prepaid card, and electronic billing products and services to businesses, merchants, and consumers. The company's reportable operating segments are Output Solutions and Merchant Services, and these segments.